Previous Close | 19.26 |
Open | 19.26 |
Bid | 20.05 |
Ask | 21.50 |
Strike | 47.50 |
Expire Date | 2026-01-16 |
Day's Range | 19.26 - 19.26 |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
SANTA MONICA, Calif., May 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced 12 abstracts from its industry-leading Chimeric Antigen Receptor (CAR) T-cell therapy portfolio at the upcoming 2024 European Hematology Association (EHA) Annual Congress, June 13-16, Madrid, Spain.
NORTHAMPTON, MA / ACCESSWIRE / May 14, 2024 / Olivia Sloan was pursuing a career in health policy and research when her father was diagnosed with non-Hodgkin lymphoma. The devastating news put her work on hold as she returned home to Santa Fe, New ...
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.